Site içinde arama yapın

Rutuja Deshmukh bir ses eklendi Other
2026-07-21 07:41:56 -

Nuclear Medicine Market Growth Analysis by Product Type
The global Nuclear Medicine Market was valued at USD 21.3 billion in 2025 and is projected to grow from USD 24.1 billion in 2026 to USD 38.2 billion by 2033, expanding at a CAGR of 6.8% from 2026 to 2033. North America dominated the market with the largest revenue share of 42.8% in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and increasing...

0 Yorumlar 0 hisse senetleri 12 Views 0 önizleme

Please log in to like, share and comment!
Aarya Jain bir ses eklendi Health
2026-05-08 06:30:55 -

Theranostics Market Witnesses Strong Growth in Nuclear Medicine and Imaging Technologies
Biomarker Diagnostics Market: Advancing Precision Medicine Through Early Disease Detection Biomarker diagnostics is rapidly transforming modern healthcare by enabling earlier, more accurate, and more personalized disease detection. Biomarkers are measurable biological indicators—such as genes, proteins, or metabolites—that provide critical insights into normal biological processes,...

0 Yorumlar 0 hisse senetleri 941 Views 0 önizleme

Please log in to like, share and comment!
Rutuja Deshmukh bir ses eklendi Other
2026-07-15 11:17:44 -

PET Scanners Market Supply Chain Analysis
The global PET Scanners Market was valued at USD 2.04 billion in 2023 and is projected to reach USD 3.37 billion by 2030, expanding at a CAGR of 3.65% from 2024 to 2030. Market growth is primarily driven by continuous advancements in positron emission tomography (PET) imaging technology, increasing adoption of precision diagnostics, rising demand for radiopharmaceutical analysis, and...

0 Yorumlar 0 hisse senetleri 85 Views 0 önizleme

Please log in to like, share and comment!
Rutuja Deshmukh bir ses eklendi Other
2026-07-15 11:18:26 -

PET Scanners Market Supply Chain Analysis
The global PET Scanners Market was valued at USD 2.04 billion in 2023 and is projected to reach USD 3.37 billion by 2030, expanding at a CAGR of 3.65% from 2024 to 2030. Market growth is primarily driven by continuous advancements in positron emission tomography (PET) imaging technology, increasing adoption of precision diagnostics, rising demand for radiopharmaceutical analysis, and...

0 Yorumlar 0 hisse senetleri 77 Views 0 önizleme

Please log in to like, share and comment!